60 Degrees Pharmaceuticals appoints Eric Francois to Board of Directors

60 DEGREES PHARMACEUTICALS, INC.

Eric Francois appointed to board effective May 13, 2026; compensation consistent with standard non-employee director arrangements.
Francois brings over 20 years of healthcare and life sciences leadership; currently independent director at CERo Therapeutics (CERO).
Previously CFO of SCYNEXIS (SCYX), raised over $300M through FDA approval and launch; earlier MD in healthcare investment banking at Raymond James and Credit Suisse.
No family relationships or material transactions with company; appointment not pursuant to any arrangement with others.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Eric Francois

Member of the Board

SXTP · 60 DEGREES PHARMACEUTICALS, INC.

Effective: 2026-05-13
Filed: May 18, 2026 20:33 UTC

On May 13, 2026, the Board of Directors (the “Board”) of 60 Degrees Pharmaceuticals, Inc. (the “Company”) appointed Eric Francois to serve as a member of the Board, effective immediately.

Source: SEC EDGAR

accession 0001213900-26-058495

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.